Deciphera Pharmaceuticals (DCPH) Misses Q4 EPS by 3c

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q4 EPS of ($0.60), $0.03 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $36.35 million versus the consensus estimate of $35.67 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

You May Also Be Interested In

• Truist Financial Corp. (TFC) Tops Q2 EPS by 15c
• South Plains Financial Inc. (SPFI) Tops Q2 EPS by 1c
• Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue